Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Rheumatoid arthritis patients have double the risk of heart failure

04.02.2005


Mayo Clinic researchers have found that rheumatoid arthritis patients have twice the risk of heart failure, or a weakening of the heart’s ability to pump blood, as those without rheumatoid arthritis, according to a new study to be published in the February edition of the journal Arthritis & Rheumatism. About one-third of the rheumatoid arthritis patients studied developed heart failure over 30 years of the disease.

"We decided to undertake this study because we knew that patients with rheumatoid arthritis die earlier than the general population, and mostly from heart disease," says Paulo Nicola, M.D., Mayo Clinic research fellow in the Department of Health Sciences Research and study author. "We thought heart failure could be a reason for early mortality in these patients. However, we were not expecting that the incidence of heart failure would be so high."

The study found that patients with rheumatoid arthritis are at an increased risk for heart failure soon after the onset of arthritis and that this elevated risk follows them throughout the course of the arthritis, a chronic disease. The researchers also found that the factors putting them at this increased risk for heart failure seem to be unrelated to heart attacks and to the traditional cardiovascular risk factors: diabetes; alcohol abuse; and elevated cholesterol, blood pressure and body mass index. The source of the increased risk remains a mystery, however.



"We expected heart attacks and traditional cardiac risk factors to contribute to the increased risk of heart failure in rheumatoid arthritis patients, but they did not," says Dr. Nicola. "This suggests another mechanism is at work. We suspect that it has something to do with the underlying inflammation that occurs in people with rheumatoid arthritis. Another possibility is that patients with rheumatoid arthritis are particularly vulnerable to develop heart disease through a mechanism that we don’t yet understand. These observations may also suggest the potential presence of a common susceptibility for developing rheumatoid arthritis or cardiac heart failure, or a shared origination of these diseases."

The study’s researchers also noted little difference between rates of heart failure in men and women with rheumatoid arthritis.

"This is quite different from what you’d find in the general population, where rates of heart failure are significantly higher among men than in women," says Dr. Nicola. "This suggests that whatever protects women from heart failure compared with men in the general population is not the same in patients with rheumatoid arthritis."

Heart failure is a serious disease, according to Dr. Nicola, causing a survival as short as most cancers. He indicates that in the general population, about one-half of heart failure patients die within three to five years.

At present, the study investigators cannot prescribe preventive measures for rheumatoid arthritis patients to take in order to avoid heart failure; they suggest that this is a subject for further study. The Mayo researchers also are conducting studies to find out which rheumatoid arthritis patients are at highest risk for heart failure and to identify whether arthritis medications are protective or contributors to heart failure.

In the meantime, Dr. Nicola says, "Patients with rheumatoid arthritis should be vigilant regarding reducing their traditional cardiac risk factors. Their physicians should have a high degree of suspicion of heart failure -- for example, they should be suspicious when rheumatoid arthritis patients relate that they are more tired than normal."

Lisa Lucier | EurekAlert!
Further information:
http://www.mayo.edu
http://www.rheumatology.org

More articles from Health and Medicine:

nachricht Cholesterol-lowering drugs may fight infectious disease
22.08.2017 | Duke University

nachricht Once invincible superbug squashed by 'superteam' of antibiotics
22.08.2017 | University at Buffalo

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

Cholesterol-lowering drugs may fight infectious disease

22.08.2017 | Health and Medicine

Meter-sized single-crystal graphene growth becomes possible

22.08.2017 | Materials Sciences

Repairing damaged hearts with self-healing heart cells

22.08.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>